There is only limited evidence to support the use of alpha-2 agonists such as clonidine to improve sleep onset latency in individuals with ADHD (Prince et al., 1996; Wilens et al., 1994) and even less data to support the use of trazodone (Bruni et al., 2018). Here, PSMA2 is linked to attention deficit-hyperactivity disorder.